Lubrizol to Sell Active Pharma, Intermediates Units
Posted: March 31, 2006
The Lubrizol Corporation announced plans to sell its active pharmaceutical ingredient and intermediate compounds business facilities in Raubling, Germany, and Chennai, India (A&I), respectively, to Auctus Management GmbH (Auctus) and the current management of the active pharmaceutical ingredient business. This reportedly is Lubrizol’s fifth and last planned divestiture since it announced its intent in July to market non-core businesses with combined revenues of US$500 million. Terms of the sale were not disclosed.